MBX Biosciences, Inc. (MBX) Dividend History

MBX Biosciences, Inc. (MBX) is a biotechnology company focused on developing treatments for metabolic and cardio-metabolic diseases. The company leverages its proprietary platforms to discover and develop novel therapeutics aimed at improving patient outcomes in conditions such as non-alcoholic steatohepatitis (NASH) and related metabolic disorders.

Website: https://www.mbxbio.com

Dividend History

MBX Biosciences, Inc. currently does not pay dividends

Company News

  • MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

    MBX Biosciences, a clinical-stage biopharmaceutical company, announced presentations at the American Diabetes Association's 85th Scientific Sessions. The presentations will focus on the safety, pharmacokinetics, and pharmacodynamics of their investigational drug MBX 1416, a GLP-1 receptor antagonist, for the treatment of post-bariatric hypoglycemia.

    GlobeNewswire Inc.
Page data last updated 08/19/2025 16:54:19 UTC